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Methods and Results. We prospectively studied 60 patients undergoing elective vascular surgery. We performed 20MT1 scintigraphy preoperatively and blinded all treating physicians to the results. Historical, clinical, laboratory, and physiological data were gathered throughout hospitalization. Myocardial ischemia was assessed during the intraoperative period using continuous 12-lead electrocardiography (ECG) and transesophageal echocardiography (TEE) and during the postoperative period using continuous two-lead ambulatory ECG. Adverse cardiac outcomes (cardiac death, myocardial infarction, unstable angina, severe ischemia, or congestive heart failure) were assessed daily throughout hospitalization. Twenty-two patients (37%) had defects that improved or reversed on delayed scintigrams (redistribution defects), 18 (30%Yo) had persistent defects, and 20 (33%) had no defects on`lTI scintigraphy. There was no association between redistribution defects and adverse cardiac outcomes: 54% (seven of 13) of adverse outcomes occurred in patients without redistribution defects, and the risk of an adverse outcome was not significantly increased in patients with redistribution defects (relative risk 1.5, 95% confidence interval 0.6-3.9, p=0.43). Consistent with these findings, there was also no association between redistribution defects and perioperative ischemia: 54% (19 of all 35) of perioperative ECG and TEE ischemic episodes and 58% (14 of 24) of severe ischemic episodes occurred in patients without redistribution defects. The sensitivity of 20`TI scintigraphy for perioperative ischemia and adverse outcomes ranged from 40%Y to 54%, specificity from 65% to 71%, positive predictive value from 27% to 47%, and negative predictive value from 61% to 82%. Conclusions. These results differ from those of previous studies and suggest that the routine use of 2'TI scintigraphy for All scintigrams were interpreted from the computer display using a semiquantitative scoring system employing a 0-to-3 scale (0, no abnormality; 1, mildly decreased uptake; 2, moderately decreased uptake; and 3, uptake reduced to the level of background activity). In addition, circumferential profiles of relative activity were generated for the stress and delayed scintigrams, and these were used as adjuncts to the visual analysis. Abnormalities were not read on the basis of the profiles alone. Each set of images was divided into a total of nine segments that were scored individually.9,19 The scintigrams were classified as normal if no defects were observed, as having a persistent defect if the initial abnormality was unchanged on the delayed image, or as having a redistribution defect if the initial abnormality resolved completely or in part (by a grade of 1 or more) on the delayed scan. Interobserver differences in interpretation were resolved by consensus. The '01T1 studies were not analyzed until the patient was discharged from the hospital. The two independent investigators interpreting the scintigrams were blinded to the patient's identity and all other measurements and outcomes. Their scintigraphic findings were, and have been, kept confidential from all referring and treating physicians.
The dipyridamole infusion resulted in a decrease in the mean+SD systolic blood pressure from 137+ 21 to 127+21 mm Hg and an increase in the heart rate from 71 + 14 to 78 + 14 beats/min (both p=0.001). In two of the 60 patients (one with a redistribution defect, one with a persistent defect), chest pain occurred and resolved spontaneously without treatment within 1 minute. One additional patient (with a redistribution defect) had four episodes of ECG ST segment depression, three of which were silent. No other complications, such as dysrhythmia, congestive heart failure, or myocardial infarction, occurred during dipyridamole testing.
Monitoring
Echocardiography. TEE was performed continuously from anesthetic induction until skin closure using a 3. 3 hr/patient). Signal detection was based on a noise-filtered, time-averaged complex for each lead. All possible ischemic episodes were reviewed independently by two investigators blinded to the patient's outcome, using ST segment criteria previously described. 22 Patients were monitored using a two-channel AM Holter ECG recorder (Series 8500, Marquette Electronics) for 2 days postoperatively (mean monitoring time 37.8 hr/patient). Fiftyfive of 60 patients had interpretable data. The frequency response of the recorders is 0.5-80 Hz at -3 dB. Two bipolar leads, CC5 and CM5, were used.22 Silver/silver chloride electrodes were used, and skin impedance was less than 5 kQO in all patients. The effect of positional variation on ECG morphology was measured before study in the supine, upright, left lateral decubitus, and right lateral decubitus positions. Patients were instructed to keep a diary of activity and symptoms during the postoperative period and were questioned daily by a study physician. Holter tapes were analyzed for ST segment deviation after all abnormal QRS complexes such as ventricular ectopic beats and beats with conduction abnormalities were excluded. The ST segment was then trended continuously in the two leads for the duration of the tape. The baseline ST segment level was defined as the average ST segment over a stable period (usually 15-60 minutes) preceding each episode. All possible ischemic episodes (using individual ECG complexes) were reviewed independently by two investigators blinded to the patient's identity and clinical course. (The variability of ECG interpretation in our laboratory has been previously reported15; interobserver, intraobserver, and interexamination concordances exceed 94%.) ECG ischemic episodes were defined as reversible ST segment changes lasting at least 1 minute and involving either a shift from baseline (adjusted for positional changes) of 1.0 mm (0.1 mV) or more of ST depression with a slope of 0 or less or a 2.0-mm or more ST elevation at the J point. ST segment depression was measured 60 msec after the J point unless that point fell within the T wave, in which case it was shortened to a minimum of 
Data Analysis
Potential univariate predictors of adverse cardiac outcomes were identified using x2 analysis or Fisher's exact test (for dichotomous predictors)24 and logistic regression (for categorical and continuous predictors).25 Continuous variables were compared using analysis of variance for repeated measures; these values are reported as mean± SD. The x2 analysis was used to compare the characteristics of patients with redistribution, persistent, or no defects.24 Twosided probability values and 95% confidence intervals are reported. All analyses were performed using SAS software (SAS Institute Inc., Cary, N.C.).
Results
The patients were typically middle-aged or elderly men who smoked and had a history of hypertension and chronic medical problems (Table 1 ). There were similar numbers of patients in each of the three scintigraphic groups (redistribution defects, persistent defects, and no defects), and there were no substantial differences in their demographic characteristics, with the exception of diabetes mellitus, which was more common in the group with no defects. Adverse Cardiac Outcomes Thirteen patients (22%) had in-hospital adverse cardiac outcomes, hierarchically classified as fatal myocardial infarction in one, nonfatal myocardial infarction in two, unstable angina or severe postoperative ischemia in five, and congestive heart failure in five. Six of these had redistribution defects, four had persistent defects, and three had no defects on oped congestive heart failure postoperatively. The sensitivity of redistribution defects for in-hospital outcomes was 46%, the specificity was 66%, the positive predictive value was 27%, and the negative predictive value was 82% (Table 3 ). The association of redistribution defects with adverse cardiac outcomes was not significant (p=0.43). Similarly, the association of persistent defects with adverse outcomes was not significant (p=0.97); the sensitivity was 46%, the specificity was 53%, the positive predictive value was 21%, and the negative predictive value was 78%. For any abnormality (reversible or persistent) the sensitivity was 77%, the specificity was 36%, the positive predictive value was 25%, and the negative predictive value was 85%. No significant association was found between reversible or persistent defects and adverse cardiac outcome (p=0.38).
Perioperative Myocardial Ischemia Thirty-five patients (58%) had perioperative myocardial ischemia. Intraoperative ECG ischemia occurred in 18 of 60 (30%), intraoperative TEE changes indicative of ischemia in 13 of 50 (26%), and postoperative ECG ischemia in 20 of 55 patients (36%). Patients with redistribution defects had a higher incidence of intraoperative and postoperative ECG and TEE ischemia than patients with persistent or no defects, but the differences were not significant (Table 4) (Table 5) . These results have generated strong arguments that 20'11 scintigraphy be used to identify at-risk patients undergoing vascular surgery.
Because our findings differ from those of the previous studies and suggest a more limited role for the use of preoperative 2QVfl scintigraphy, it is important to examine the similarities and differences between these studies and ours. With respect to similarities, both our study and the previous six studies cited9-14 1) addressed the same general patient population (viz., patients undergoing vascular surgery), 2) used similar techniques for performing 201Tf scintigraphy, and 3) measured similar outcome variables. However, a number of differences exist, including 1) the use of consecutive versus selected patients, 2) blinding of the clinicians to the scintigraphy results, 3) perioperative clinical management of patients, 4) intensity of outcome variable measurements, and 5) measurement of perioperative myocardial ischemia as an intermediate of outcome. Each difference will be discussed in turn.
First, with respect to the patient population, patients in our study were consecutively enrolled, whereas most previous studies did not enroll consecutive patients but included only those patients referred by a consulting physician13"4 or patients presumed to be at higher risk. longer than 3 hours between scintigrams or using a reinjection technique would have improved the sensitivity of the test since several of the persistent defects may have redistributed over longer periods. However, four of the early studies9"10"13,14 used a similar 3-hour delay, with the fifth study11 using a 2.5-3-hour delay and the sixth study12 using a 3-4-hour delay. Our findings with respect to adverse cardiac outcomes were substantiated by the perioperative ischemia results. We found that 201T1 scintigraphy in our surgical population was not particularly sensitive or specific for the detection of intraoperative ECG or TEE indices of ischemia, postoperative ischemia, or adverse cardiac outcomes (cardiac death, myocardial infarction, unstable angina, severe ischemia, or congestive heart failure). In fact, the majority of all ischemic episodes (54%), severe ischemic episodes (58%), and adverse cardiac outcomes (54%) occurred in patients without redistribution defects.
Our findings should not be completely surprising, however. Multiple physiological changes, including marked increases in myocardial oxygen demand,3738 occur perioperatively. The preoperative disease state may be only one factor that affects outcome. Even in patients with stable preoperative disease (for example, no redistribution defect), multiple physiological changes that can adversely affect outcome (fluid shifts, aortic cross-clamping, respiratory effects, incisional pain, temperature changes) could occur intraoperatively and postoperatively. In addition, 201T1 scintigraphy assesses only those changes that may occur with alteration of relative perfusion to the heart. This technique, therefore, may be an insensitive test for the prediction of ischemic events that are triggered primarily by increases in myocardial oxygen demand. Furthermore, thrombotic complications, which often occur at the site of noncritical lesions, may not be predictable by stress scintigraphy.
Several other points merit comment. The use of improved scintigraphic techniques and stress procedures, such as hand-grip exercise, SPECT, reinjection techniques, or semiquantitative analysis,39 might have increased our sensitivity for reversible defects. However, none of these procedures, as stated earlier, were used in previous studies reporting a higher sensitivity and nearly perfect negative predictive value. Furthermore, all of these approaches are likely to increase the number of patients with reversible defects who do not have adverse outcomes. Such a result would not help achieve the goal of detecting a small high-risk group. Second, although we studied 60 patients intensively, an argument can always be made for studying more patients, especially when a negative result is discovered. However, our principal findings would not have changed even if a substantially larger population were studied. For example, to achieve the same sensitivity for adverse outcomes as previous studies (90%), an additional 342 patients would have to be studied and all 57 outcomes (13%) would have to occur only in those patients with redistribution defects.
In conclusion, our results suggest that preoperative '1Tl scintigraphy has limited sensitivity for the detection of perioperative ischemia or adverse cardiac outcome and a lower negative predictive value than previously appreciated. Our findings differ from those of previous studies and suggest that the routine use of 20'1l scintigraphy for preoperative screening of patients undergoing vascular surgery may not be warranted.
